2026 AI for Mental Health (AI4MH) Symposium: Industry & Translation —What It Takes to Deploy

Why It Matters

Because AI mental‑health assistants are already a utility for billions, establishing architectural governance and journey‑based evaluation is essential to protect users and legitimize large‑scale deployment.

Key Takeaways

• AI mental‑health tools act as utilities, not just products.
• User journey, not single chat, must be evaluation metric.
• Safety handoffs often fail; referrals rarely result in actual help.
• Architectural governance distributes responsibility across developers, clinicians, crisis lines.
• OpenAI uses dual model and product policies for risk detection, tailored interventions.

Summary

The AI4MH symposium’s industry and translation session examined how artificial‑intelligence mental‑health solutions move from research labs to real‑world clinics. Speakers highlighted the urgency of scaling tools responsibly, addressing safety, evaluation, and regulatory challenges while treating AI as a public‑health utility rather than a simple product.

Gina Sue argued that the unit of assessment must expand from a single conversation to the entire user journey, noting that many users seek AI because human services feel costly or burdensome. She cited a participant who felt frightened after an AI‑provided suicide‑hotline suggestion, and data showing most referrals never result in a call—underscoring gaps between offered resources and actual outcomes. She framed the problem as an architectural one, requiring distributed governance among model developers, clinicians, and crisis‑line operators.

Sarah Johansson described OpenAI’s two‑layer policy framework: model policy trains the system to recognize risk signals and bound unsafe responses, while product policy layers additional interventions that direct users to appropriate offline support. She emphasized continuous risk detection across conversations and the need for context‑aware redirection, illustrating how a billion‑user scale demands coordinated safeguards.

The discussion signals that successful deployment will hinge on sociotechnical design—standardizing governance structures while preserving individualized responses. Regulators and investors must demand journey‑level metrics, transparent handoff mechanisms, and shared accountability across the ecosystem to ensure AI‑driven mental‑health tools improve outcomes without unintended harm.

Original Description

This session explores what it takes to move AI in mental health from research to real-world deployment. Industry leaders discuss scaling, safety, evaluation, and regulatory realities in clinical settings. The focus is on bridging innovation with responsible execution at scale.

Speakers:

Russ B. Altman — Kenneth Fong Professor and Professor of Bioengineering, of Genetics, of Medicine, of Biomedical Data Science, Senior Fellow at the Stanford Institute for Human-Centered AI and Professor, by courtesy, of Computer Science, Stanford University

Sara Johansen — Product Policy Lead for Mental Health and Well-Being, OpenAI

Jina Suh — Principal Researcher, University of Washington, SafeMind Institute

This symposium was recorded on June 1, 2026 at Stanford University.